SBWire

Global Market Direct's pharmaceuticals report, "Uni-Bio Science Group Ltd. - Product Pipeline Review - 2012" provides data on the Uni-Bio Science Group Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Markets Direct's, 'Acinetobacter Infections - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Acinetobacter Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acinetobacter Infections. Acinetobacter Infections - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Bronchiolitis Obliterans - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Bronchiolitis Obliterans, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bronchiolitis Obliterans. Bronchiolitis Obliterans - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Market Direct's pharmaceuticals report, "Envoy Therapeutics, Inc. - Product Pipeline Review - 2012" provides data on the Envoy Therapeutics, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "Reviva Pharmaceuticals Inc. - Product Pipeline Review - 2012" provides data on the Reviva Pharmaceuticals Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "Genentech, Inc. - Product Pipeline Review - 2012" provides data on the Genentech, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

The China Insurance Report considers the prospects for both life and non-life insurers in that country. In spite of the slowing in the growth rate of premiums, it appears that China's life insurers should continue to be major beneficiaries of the growth in organised savings in the country. Encouragingly, some of the factors which curtailed growth in 2011 - lingering inflation and regulatory changes imposed by the China Banking Regulatory Commission (CBRC) which hindered bancassurance - have clearly diminished in importance since the beginning of this year. The major life companies are, in most cases, looking to increase the size, number and productivity of channels that do not depend on collaboration with banks. Against this, we note that the rather patchy performance of China's financial markets will complicate any capital raisings by major players who need more funds for their growth. As is the case in other countries, low interest rates have provided the major life insurers with a challenge through H112.

The political and economic situation in Belgium during the second half of the review period was decidedly unstable due to the effects of the European economic crisis and the absence of a government in Belgium for nearly two years. With the eventual installation of new Belgian government came a wave of unpopular new financial measures, including a raft of new taxes and cuts to unemployment benefits. However, this negative politico-economic situation did not negatively affect sales of pet care...

In 2011, the Vietnamese economy shows signs of slowing down and instability. Soaring inflation, coupled with slower GDP growth, led to consumer electronics seeing slightly weaker retail volume sales growth compared to 2010. The further devaluation of the Vietnamese dong against the US dollar, together with increasing market maturity, also negatively affected performance. All of these factors contributed to consumers tightening their budgets, particularly those in the lower to middle income...

After a surge in volume sales in 2010, 2011 was a strong contrast as consumer electronics posted a marginal volume decline. Following the recovery and stronger consumer sentiment in 2010, 2011 was a more tumultuous year with a sluggish economic situation leading to consumers being more discriminating in their purchases, especially for consumer electronics. While demand for a number of gadgets such as smartphones and tablets was not weakened by the economic situation, volume growth slowed down...

The figures of National Institute of Statistics confirm that the number of working women constitutes 32% of the total number of workers in Tunisia, and this number increases by 7% each year. Another important figure from the same source confirms that 8 out of 10 women aged between 18 and 40 years are using beauty and personal care.

Disposable incomes and consumer expenditure have been growing in Mexico. Income disparity is high. Poverty affects many people, from children to pensioners; yet, the middle-class is growing. The population is ageing, but the proportion of young people is high. The lack of education and socio-economic factors affects consumer behaviour and spending habits. Pirated goods are common; the informal sector plays a major role and violence is a concern in parts of the country.

The Japanese life insurance segment is the second-largest life insurance segment in the world in terms of gross written premium behind the US. The Japanese life insurance segment grew during the review period (2007-2001) due to an aging population and a growth in the volume of single-person households. Japan's aging population drove consumer attention towards post-retirement savings. This is expected to become a key driver for the segment over the forecast period.

Global Market Direct's pharmaceuticals report, "Phico Therapeutics Ltd. - Product Pipeline Review - 2012" provides data on the Phico Therapeutics Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "Ardelyx, Inc. - Product Pipeline Review - 2012" provides data on the Ardelyx, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "GlycoVaxyn AG - Product Pipeline Review - 2012" provides data on the GlycoVaxyn AG's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

We do not envisage a strong pickup in Vietnamese exports due to growing evidence of a lacklustre recovery in global demand in 2013, which will have a knock-on effect on the country's freight industry. Additionally, Vietnam's main export partners, the US, China and Japan, are all finding it hard to shake off the economic hangover of 2012. That said, Vietnam's economy remains on track for a robust recovery in 2013, and we view consensus estimates on growth as being overly pessimistic. Also, looking at the breakdown of exports, we are seeing encouraging evidence that Vietnam is becoming less reliant on refined crude imports (dominantly petroleum imports) and could soon become a net exporter of crude oil over the coming years.

With new vehicle sales falling almost 21% year-on-year (y-o-y), to 48,780 units, between January and August, according to estimates from the Vietnam Automobile Manufacturers' Association, our forecast of a more than a 26% y-o-y contraction in 2012 looks firmly on the cards.

The Saudi Arabia Real Estate report examines the commercial office, retail, industrial and construction segments throughout the kingdom in the context of a bullish outlook for the economy, its buoyant construction sector and the fledgling weakness in the commercial real estate rental market.

Our forecasts suggest household expenditure will cool through H212 and into 2013 following a prolonged period of very strong private consumption growth. This already appears to playing out in second-quarter retail data, with retail sales growth averaging 6.7% year-on-year (y-o-y), down from 7.6% in Q112, and new motor vehicle sales registrations experiencing an even more aggressive slowdown (see chart). Part of the reason for this slowdown is the very high base set in H210 and 2011, when real private consumption growth averaged a strong 6.7%, a rate which will be hard to match over coming quarters.

Chile continued to experience widespread disaffection with government in 2012, leading to a number of protests that saw police forces resort to teargas and water cannons to disperse demonstrators. While the country's external security conditions remain relatively stable and benign, Chile's internal security environment continues to be threatened by the dissonance between Sebastian Pinera's rightist administration and large sections of society demanding social and economic changes.

GlobalData's new report, "Spain Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others" provides key market data on the Spain Diagnostic Imaging market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within 10 market categories - Angio Suites, Bone Densitometers, C-Arms, Computed Tomography Systems, Contrast Media Injectors, Mammography Equipment, MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems and X-ray Systems. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

GlobalData's clinical trial report, "Dementia Global Clinical Trials Review, H2, 2012" provides data on the Dementia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dementia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dementia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's clinical trial report, "Hyperthyroidism Global Clinical Trials Review, H2, 2012" provides data on the Hyperthyroidism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperthyroidism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyperthyroidism. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Two months ago it was concluded that the recruitment of Norwegian Xocai distributors had increased by 103%, from about 75 new Norwegian distributors per week to about 158. The effect of the massive positive media attention this summer therefore had a tremendous impact on the further spread of the "Healthy Chocolate" concept and it looks like this trend also spread internationally. Since 2008, the recruitment pace has been increased by 2/3 on a global scale and this year in particular has been a historical high for the company with over 11,220 new distributors enlisted.